Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-08-16 Labrucherie Gil M SVP & Chief Financial Officer Returned to the company −8,207 $58.40 $479K 113,059
2018-08-16 Hora Maninder SVP Pharma Dev & Mfg Ops Returned to the company −5,946 $58.40 $347K 85,723
2018-08-16 ROBIN HOWARD W President & CEO Returned to the company −20,389 $58.40 $1.2M 264,467
2018-08-16 Doberstein Stephen K SVP & Chief Scientific Officer Returned to the company −6,701 $58.40 $391K 83,258
2018-08-15 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award +10,400 76,148
2018-08-15 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Stock Option +26,250 26,250
2018-08-15 Nicholson John SVP & Chief Operating Officer Grant or award +26,000 188,596
2018-08-15 Nicholson John SVP & Chief Operating Officer Grant or award · Stock Option +65,000 65,000
2018-08-15 Labrucherie Gil M SVP & Chief Financial Officer Grant or award +26,000 121,266
2018-08-15 Labrucherie Gil M SVP & Chief Financial Officer Grant or award · Stock Option +65,000 65,000
2018-08-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award +15,000 91,669
2018-08-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +37,500 37,500
2018-08-15 ROBIN HOWARD W President & CEO Grant or award +60,500 284,856
2018-08-15 ROBIN HOWARD W President & CEO Grant or award · Stock Option +151,250 151,250
2018-08-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award +26,000 89,959
2018-08-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +65,000 65,000
2018-08-14 ROBIN HOWARD W President & CEO Grant or award +40,000 $10.69 $428K 264,356
2018-08-14 ROBIN HOWARD W President & CEO Returned to the company −40,000 $60.08 $2.4M 224,356
2018-08-14 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −40,000 0
2018-08-14 WINGER DENNIS L Director Sale −17,125 $60.15 $1.0M 42,750

Page 30 of 43 · 847 trades